July 23, 2025

Figure 3 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

THTae HataKyoto Prefectural University TYTadaaki YamadaKyoto Prefectural University of Medicine YGYasuhiro GotôFujita Health University

Discussion

Member takes

Implication

Kaplan-Meier curves show overall survival and progression-free survival in patients with liver metastases, indicating treatment effects of chemoimmunotherapy.

Key Points

Patients with liver metastases treated with ICI plus chemotherapy show different overall survival outcomes than those on chemotherapy alone.
Progression-free survival rates differ significantly based on treatment type in patients with non-small cell lung cancer.
The study utilizes Kaplan-Meier curves to analyze treatment outcomes in advanced lung cancer stages stratified by liver metastasis presence.
Findings emphasize the importance of treatment strategy in improving cancer prognosis for patients with low PD-L1 expression.

Cite This Study

Hata et al. (2025) studied this question.

synapsesocial.com/papers/689a0621e6551bb0af8cdb86 https://doi.org/10.1158/2767-9764.29624063

View Full Paper

Ask AI

Bookmark

Implication

Kaplan-Meier curves show overall survival and progression-free survival in patients with liver metastases, indicating treatment effects of chemoimmunotherapy.

Figure 3 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Figure 3 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider